글로벌 단일 세포 유전체학 및 프로테오믹스 시장 – 2030년까지의 산업 동향 및 예측

단일 세포 유전체학 및 프로테오믹스 시장 분석 및 규모

제약 및 생명공학 R&D 비용과 프로테오믹스에 대한 정부 자금 지원이 시장 성장을 촉진하는 데 필수적입니다. 프로테오믹스, 유전체학, 전사체학 및 대사체학에서 SCA(단일 세포 분석)에 대한 필요성이 증가하고 있습니다. 혁신적인 연구 및 자금 지원을 위한 분석 도구에 대한 수요가 증가함에 따라 고처리량 장비가 널리 도입되었습니다.

Data Bridge Market Research는 2022년에 35억 달러였던 단일 세포 유전체학 및 프로테오믹스 시장이 2030년까지 110억 8천만 달러로 증가할 것으로 분석하고, 2023년에서 2030년까지의 예측 기간 동안 15.50%의 CAGR을 보일 것으로 예상합니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

단일 세포 게놈학 및 프로테오믹스 시장 범위 및 세분화

시장 정의

단일 세포 유전체학은 세포의 이질성을 조사하고 임상 결과와 관련된 새로운 분자적 특성을 식별하는 방법입니다. 이 전략은 다세포 또는 대량 조직 샘플을 분석할 때 발생하는 데이터 손실 없이 샘플에서 세포 다양성의 복잡성을 식별하는 데 도움이 됩니다.

글로벌 단일 세포 유전체학 및 프로테오믹스 시장 역학

운전자

• 시장 개발을 위한 자금 조달 증가

시장 개선을 위해 자금을 지원받고 있는 회사는 많습니다. 예를 들어, 미국 기업인 Deepcell Inc.는 AI 기반 단일 세포 분석 플랫폼을 개선하고 2022년 상용화를 향해 나아가기 위해 7,300만 달러의 자금을 지원받았습니다. 따라서 주요 시장 참여자들은 향후 몇 년 동안 수익을 창출하기 위한 솔루션 개발에 투자하는 것을 고려하고 있습니다. 이러한 요인은 시장 성장으로 이어집니다.

• 암 유병률 증가

According to the American Cancer Society, cancer is the second most common cause of death in the U.S. As per the cancer statistics, in 2022, around 1.9 million new cancer cases are anticipated to occur in the U.S. This increasing incidence of cancer demands more and more studies and experiments, which further demands the use of SCA genomics and proteomics. Thus, this factor boosts market growth.

Opportunities

• Increasing Technological Advancements by Market Players

Several technologies, such as the development of next-generation sequencing for analyzing cellular expressions, mass spectrometry, and FISH (Fluorescence in situ hybridization), are greatly helping in the process of SCA. Furthermore, the market is witnessing the growing automation of machines and artificial intelligence for data analysis. Numerous software and computational methods have been developed and used because of their benefits, such as flexibility, scalability, and high success rates. For instance, there were more than 1000 single-cell RNA analysis tools in 2021. Thus, this factor boosts market growth.

• Increased Partnerships between Organizations and Market Players

There have been increasing partnerships between several organizations and market players, leading to the market's growth. For instance, Lifebit announced its partnership with Boehringer Ingelheim in 2022. The partnership will use the Cloud O.S. of Lifebit, the first federated platform for genomics, to build a data analytics infrastructure for Boehringer. Boehringer was also related to Lifebit's REAL platform in 2021 to increase the detection and tracking of disease outbreaks. Thus, this factor boosts market growth.

Restraints/Challenges

• High Cost of Proteomic Instruments

The high cost of proteomics instruments leads to market hindrances as they cannot be appointed by many underdeveloped nations' hospitals and research institutes. Also, a lot of maintenance is required to keep the consistency good. Thus, this factor impedes market growth.  

This single cell genomics and proteomics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the single cell genomics and proteomics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2021, the HIVETM scRNAseq Solution for single-cell isolation and analysis was launched by PerkinElmer, Inc. and Honeycomb Biotechnologies, Inc. This is a portable device used by the HIVE solution to capture, store, and prepare RNA-Seq libraries for several cell types, including fragile and labile cells such as granulocytes, nephrons, hepatocytes, and neurons.
• In 2021, CytoFlex SRT Benchtop Cell Sorter from Beckman Coulter Life Sciences was launched, which includes extended laser and color options for use in labs of all sizes. With the initiation of new technology, automating, streamlining, and stream maintenance became easy.

Global Single Cell Genomics and Proteomics Market Scope

The single cell genomics and proteomics market is segmented on the basis of single cell genomics process step, single cell genomics analytical technology, proteomics components, proteomics reagents, proteomics services & software, single cell genomics applications, proteomic application and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Single Cell Genomics Process Step

• Cell isolation
• Sample Preparation
• Genomics Analysis

 Single Cell Genomics Analytical Technology

• Tubing PCR
• Qpcr
• Microarray
• Next-Generation-Sequencing
• Other

 Proteomics Components

• Instruments
• Reagents
• Services

Proteomics Reagents

• Immunoassay Reagents
• Spectroscopy Reagents
• Chromatography Reagents
• Protein Microarray Reagents
• X-Ray Crystallography Reagents
• Electrophoresis Reagents
• Protein Fractionation Reagents

Proteomics Services & Software

• Core Proteomics Services
• Bioinformatics Software & Services

Single Cell Genomics Applications

• Genomic Variation
• Subpopulation Characterization
• Circulating Tumor Cells
• Cell Differentiation / Reprograming Method
• Others

Proteomic Application

• Drug Discovery
• Disease Diagnosis
• Other

End- Users

• Academic Institutes
• Biopharmaceutical Companies
• Clinical Research Institutes

Single Cell Genomics and Proteomics Market Regional Analysis/Insights

The single cell genomics and proteomics market is analyzed and market size insights and trends are provided by single cell genomics process step, single cell genomics analytical technology, proteomics components, proteomics reagents, proteomics services & software, single cell genomics applications, proteomic application and end-users as referenced above.

The countries covered in the single cell genomics and proteomics market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the single cell genomics and proteomics market due to multiple government funding programs, increasing awareness regarding personal healthcare and associated expenditure, high adoption of novel analytical tools and techniques, and the wide availability of trained personnel. Also, the U.S. is a major contributor to industry growth in the North American region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period because of the presence of national centers and local emerging economies offering such facilities. Furthermore, the major market players associated with this market are also enhancing the growth of the market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The single cell genomics and proteomics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for single cell genomics and proteomics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the single cell genomics and proteomics market. The data is available for historic period 2011-2021.

Competitive Landscape and Single Cell Genomics and Proteomics Market Share Analysis

단일 세포 유전체학 및 프로테오믹스 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 단일 세포 유전체학 및 프로테오믹스 시장과 관련된 회사의 초점에만 관련이 있습니다.

단일 세포 유전체학 및 단백체학 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Thermo Fisher Scientific(미국)
• QIAGEN(네덜란드)
• Agilent Technologies, Inc. (미국)
• 맥케슨 코퍼레이션(미국)
• R1 RCM 주식회사(미국)
• 올스크립트 헬스케어, LLC, (미국)
• Accenture, (아일랜드)
• 지멘스(독일)
• F. 호프만-라 로슈 유한회사(스위스)
• Bio-Rad Laboratories, Inc. (미국)
• BGI(중국)
• BD(미국)
• 다나허(미국)
• 브루커(미국)
• 10x Genomics(미국)
• 루미넥스 코퍼레이션(미국)
• 프로메가 코퍼레이션(미국)

SKU-47743